Effect of switching therapy from nucleos(t)ide analogue to pegylated-interferon in patients with chronic hepatitis B
Not Applicable
Recruiting
- Conditions
- chronic hepatitis B
- Registration Number
- JPRN-UMIN000012415
- Lead Sponsor
- Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
under age of 20 significant liver fibrosis (F3-) coinfection with HCV / HDV / HIV coexistence with other chronic liver disease pregnant or breast-feeding women contraindication to scheduled drugs patients found to be inadequate by their doctors
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method